Wedbush Keeps Their Buy Rating on Beyond Inc (BYON)
In a report released today, Michael Pachter from Wedbush reiterated a Buy rating on Beyond Inc (BYON – Research Report), with a price target of ...
Wedbush Keeps Their Buy Rating on Getty Images Holdings (GETY)
In a report released today, Michael Pachter from Wedbush maintained a Buy rating on Getty Images Holdings (GETY – Research Report), with a ...
Apple sees bullish views at Wedbush on product and AI driven services growth ahead
Wedbush maintained its Outperform rating on Apple (NASDAQ:AAPL) noting that the company's next stage of product and AI driven ...
Kiplinger4y
Wedbush: Tesla Stock Has Double-Digit Upside, But Don't Buy TSLA
Tesla (TSLA, $845.00) stock has the potential to reach $950 per share, says Wedbush analyst Daniel Ives. But he still doesn’t think you should buy it. The 11 Best Growth Stocks to Buy for 2021 ...
Wedbush Cuts Earnings Estimates for Apogee Therapeutics
Investment analysts at Wedbush reduced their Q1 2025 earnings estimates for Apogee Therapeutics in a note issued to investors on Monday, March 3rd. Wedbush analyst D. Nierengarten now forecasts that ...